Free product worth Rs 499 on all myUpchar products
Pramirol SR 0.52 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease. Secondary and off-label uses of Pramirol SR 0.52 Tablet have also been mentioned below.
The right dosage of Pramirol SR 0.52 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Pramirol SR 0.52 Tablet can also lead to other problems, which have been listed below. Such side effects of Pramirol SR 0.52 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Pramirol SR 0.52 Tablet's effect during pregnancy is Moderate and Severe while nursing. In addition, Pramirol SR 0.52 Tablet's effects on the liver, heart and kidney are discussed below in the Pramirol SR 0.52 Tablet related warnings section.
Pramirol SR 0.52 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pramirol SR 0.52 Tablet in conditions like Schizophrenia, Heart Disease, Kidney Disease.
Drug interactions for Pramirol SR 0.52 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Pramirol SR 0.52 Tablet is not safe while driving, and is is not addictive in nature.
Pramirol SR 0.52 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Pramirol SR 0.52 Tablet safe for pregnant women?
Pramirol can have harmful effects in pregnant women. If you experience any discomfort after using Pramirol, then discontinue the use and take your doctor's advice.
Is the use of Pramirol SR 0.52 Tablet safe during breastfeeding?
Taking Pramirol may lead to serious side effects if you are breastfeeding. Pramirol should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Pramirol SR 0.52 Tablet on the Kidneys?
Pramirol rarely harms the kidneys.
What is the effect of Pramirol SR 0.52 Tablet on the Liver?
Pramirol does not damage the liver.
What is the effect of Pramirol SR 0.52 Tablet on the Heart?
Very few cases of side effects of Pramirol on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Pramirol SR 0.52 Tablet unless your doctor advises you to do so -
Is this Pramirol SR 0.52 Tablet habit forming or addictive?
No, there is no any evidence that Pramirol SR 0.52 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramirol SR 0.52 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Pramirol SR 0.52 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Pramirol SR 0.52 Tablet can treat mental disorders.
Interaction between Food and Pramirol SR 0.52 Tablet
Some foods when eaten with Pramirol SR 0.52 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Pramirol SR 0.52 Tablet
Taking Pramirol SR 0.52 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
